Refine by
Obstetrician Gynecology Articles & Analysis: Older
24 news found
Onconova Therapeutics, Inc. (NASDAQ: ONTX), (“Onconova”), a clinical-stage biopharmaceutical company focused on discovering and developing novel products for patients with cancer, today announced plans for a Phase 1/2a trial of narazaciclib combined with letrozole in recurrent metastatic low-grade endometrioid endometrial cancer (LGEEC). In addition, the Company reported its third ...
Today we’d like to introduce you to Gillian Henker. Hi Gillian, we’re thrilled to have a chance to learn your story today. So, before we get into specifics, maybe you can briefly walk us through how you got to where you are today. In 2014, Gillian Henker co-founded Sisu Global, leading the company’s products and technical strategy. Henker is the primary inventor of Hemafuse ...
Aresus Pharma GmbH, a subsidiary of DERMAGO GmbH, announced today that clinical results on the efficacy of 5-10% Topical Sinecatechins (synonyms: “Polyphenon® E“, ”defined extract from green tea leaves“) Ointment for Postmenopausal Vestibulodynia1 were presented at the 2nd Congress on Women’s Health Innovations & Inventions in Tel Aviv on July 11-12th, 2022. ...
PISA, Italy, May 26,2022 - Medical Microinstruments (MMI) SpA. a robotics company dedicated to improving clinical outcomes for patients undergoing microsurgery, today announced the launch of its Symani Surgical System Simulator developed by VirtaMed. The simulator will improve, expand, and digitize the pathways for Symani training as surgeons prepare to expand their microsurgical skills through ...
KitoTech Medical, a Seattle-based medical device company, announced today that it has completed the first close of approximately $2M of its Series B Round where there is the potential to raise a total of $6M. The proceeds from the financing will be primarily used to increase KitoTech’s commercial efforts in the medical market to increase the use of and drive sales of its microMend® ...
Robocath, a company that designs, develops and commercializes robotic solutions to treat cardiovascular diseases, and Rennes University Hospital, today announce the launch of a co-development research program using robotics to improve treatment for stroke victims. With the support of Philips France, this unique program will be implemented over the next four years. It will focus on the use of ...
ByRobocath
Guided Therapeutics, Inc. (OTCQB: GTHP), the maker of the LuViva Advanced Cervical Scan, based on its patented biophotonic technology, announced today that enrollment and testing of patients has begun at the Department of Obstetrics & Gynecology Hospital of Fudan University located in Shanghai. The data will be submitted to the Chinese National Medical Products Administration (NMPA; formerly ...
Ahead of their attendance at this year’s MEDICA event, AgPlus have appointed a new Chief Scientific Officer, Dr Nic Christofides, who has vast experience of finalising late stage clinical assays to ensure commercial success. Of Cypriot descent, Dr Christofides started his career in 1973 at Hammersmith Hospital, London, as a research assistant where he developed immunoassay for Oestriol ...
Company to showcase first and only FDA-authorized surgical robot that features miniature humanoid-shaped arms and host in-booth surgeons to discuss their experiences with Hominis Tel Aviv, Israel and Fort Lauderdale, FL, November 11, 2021 – Memic Innovative Surgery (Memic), a medical device company dedicated to transforming healthcare with its proprietary surgical robotic technology, ...
Guided Therapeutics, Inc. (OTCQB: GTHP), the maker of the LuViva Advanced Cervical Scan, based on its patented biophotonic technology, announced today that its Chinese partner, Shandong Yaohua Medical Instrument Corporation (SMI), had received ethics board approval and placed LuViva devices at two of the three participating hospitals for clinical trials aimed at achieving Chinese FDA approval. ...
Guided Therapeutics, Inc. (OTCQB: GTHP), the maker of the LuViva® Advanced Cervical Scan, based on its patented biophotonic technology, announced today it had passed the regulatory compliance review at the Department of Obstetrics & Gynecology Hospital of Fudan University located in Shanghai. Clinical trials there and at three other centers are expected to begin this quarter. GTHP also ...
Guided Therapeutics, Inc. (OTCQB: GTHP), the maker of the LuViva Advanced Cervical Scan, based on its patented biophotonic technology, announced today that an independent study of 166 women in Hungary showed that LuViva detected 20% more cervical precancer and cancer than the HPV test. Specifically, LuViva had a very high sensitivity of 94%, detecting disease in 48 of 51 women with biopsy results ...
Theranica, a prescribed digital therapeutics company developing advanced electroceuticals for migraine and other pain conditions, announced today that a new peer-reviewed study published in Pain and Therapy demonstrates the efficacy of Nerivio® in treating menstrual migraine. Menstrual migraine, a sub-type of migraine, is often more painful, more disabling and of longer duration compared to ...
During the rapid demand peak for isolation rooms and effective air decontamination to fight COVID-19, a large amount of hospitals worldwide have learned that the most effective way to decontaminate air is with advanced electric decontamination. Implementing safety measures on all important fronts is crucial for the safety of hospital staff and patients. Increased cleaning, hand hygiene, usage ...
(North Andover, Massachusetts), MindChild Medical, Inc. today announced that the LABOR Study selected MindChild’s Meridian Fetal Research Device as the centerpiece of their study due to its unparalleled ability to accurately extract fetal ECG for advanced analytical research. Dr. Jeffrey Stringer, professor of obstetrics & gynecology in the UNC School of Medicine and LABOR Study ...
Osel, Inc., a company developing live biotherapeutic products (LBPs) for diseases linked to the disruption of the human microbiome, today announced clinical data showing that the company’s LACTIN-V LBP significantly reduced the recurrence of bacterial vaginosis (BV) vs. placebo in a Phase 2b trial. Results were published in the New England Journal of Medicine: “Randomized Trial of ...
Gauss, the leader in AI-enabled surgical applications, announced an over-the-air software update, Triton QBL, that pairs the company’s AI-powered blood loss monitor with integrated protocols and provider alerts that help to synchronize postpartum hemorrhage care. The update will be available to the company’s network of hospital customers this fall. The United States has the highest ...
Groningen, the Netherlands - 3 February 2017 - ViciniVax, a Dutch biopharmaceutical company in Groningen, announced today the treatment of the first patient with Vvax001 in a Phase I study in patients with a history of cervical intraepithelial neoplasia (CIN) 2 and 3 or cervical cancer. The Phase I study is an investigator-initiated Phase I clinical trial conducted by the Department of Obstetrics ...
The University of Mississippi Medical Center is one of 25 hospitals participating in the SONATA™ (SonoGraphy-Guided Transcervical Ablation) study, a clinical device trial to treat uterine fibroids. “You deliver heat energy directly to the fibroids, which can dry and shrink them,” said Dr. Jay Hudgens, assistant professor of obstetrics and gynecology and lead investigator for the ...
Presentations Highlight the PlasmaJet’s Atraumatic Approach to Surgery. Roswell, Georgia – April 15, 2015, – Plasma Surgical, creator of the PlasmaJet® Surgery System, an advanced energy-based medical device designed as a safe and effective alternative to traditional electrosurgery and other instruments, is pleased to recognize Professor Horace Roman’s presentations at ...